INEX Innovations Exchange Pte. Ltd.


1 September 2016, Singapore, INEX INNOVATIONS EXCHANGE PTE LTD is pleased to announce that iGene has been awarded the Singapore Prestige Brand Award (SPBA) under the “SPBA – Micro Brands” category today. Vinita Choolani, Vice President of Sales and Marketing and Dr. Francisco M. Gil-Salas, Head of Business Development attended the event to receive this prestigious award.

Established in 2002 by the Association of Small and Medium Enterprises (“ASME”) and Lianhe Zaobao, SPBA recognises and honours Singapore brands that are developed and managed effectively through various branding initiatives.

Ms Vinita Choolani, Vice President of Sales and Marketing commented, “We are proud to be awarded the SPBA Award in the Micro Brands category. The iGene® brand is about giving women accurate information to make informed decisions about their pregnancy, and their baby. The win is a testament to the vision, dedication and excellence of the iGene® marketing team in conceiving and developing the brand. We are also grateful to IE Singapore for their support in providing the grant to allow us to develop our brand, and to our partner labs, distributors and vendors for their support that have helped INEX achieve this milestone.”

Dr. Francisco M. Gil-Salas, Head of Business Development, INEX commented, “We are a young made-in-Singapore company within the biotech industry, with typically little brand visibility. We wanted to change this by participating in the SPBA, to show that biotech startups can have strong brands. The recognition from SPBA would also serve as a great way to build our reputation and credibility for our innovative technology, and encourage us to strive for excellence.”

About INEX Innovations Exchange
Established in 2006, Innovations Exchange Pte Ltd (INEX) is a pioneering molecular diagnostic company focused on the research, development, marketing and licensing of innovative technology for the advancement of maternal and fetal health.

INEX started as a small molecular diagnostics company ten years ago. Today, INEX holds numerous patents and licenses in key areas serving women’s health, including OvaCisTM, an ovarian cancer IVD detection kit, iGene®, a non-invasive prenatal testing, and FlashFISHTM, which performs same-day prenatal diagnosis.


About iGene
iGene® is a revolutionary non-invasive prenatal blood test that can detect fetal chromosomal abnormalities such as Down Syndrome with more than 99% accuracy. iGene® is suitable for pregnant mothers who are at 10 weeks of gestation and above.

The test has drastically changed the course of prenatal screening because it offers expectant mothers accurate results without the risk of miscarriage. It is anticipated that the use of iGene® as a prenatal screening tool can reduce the rate of invasive procedures such as amniocenteses by as much as 95%.


For more information, please contact:

Sue Voon
Senior Marketing Executive
INEX Innovations Exchange Pte Ltd
Tel: 6773 0698
Email: sue.chuah@inex.sg

Exhibitor Data Sheet